Senores Pharmaceuticals announced that it has received final approval from the United States Food and Drug Administration (USFDA) to market Metoprolol Tartrate and Hydrochlorothiazide Tablet USP, 50 ...

Shares of Senores Pharmaceuticals Ltd on Monday listed with a premium of over 53 per cent against the issue price of Rs 391. The stock made its debut at Rs 593.70, rallying 51.84 per cent from the ...

Senores Pharmaceuticals share price listed at stellar 53% premium at ₹600 on the NSE and ₹593.70 on the BSE on Monday ...

Shares of three companies namely- Senores Pharmaceuticals, Ventive Hospitality and Carrora India- made their Dalal Street ...

Senores Pharmaceuticals IPO Allotment Status: The allotment of the Senores Pharmaceuticals IPO has been finalised. The initial public offering of Senores Pharmaceuticals Ltd closed on Tuesday and ...

Retail Individual Investors (RIIs) subscribed to their reserved portion 90.46 times. Established in 2017, Senores Pharmaceuticals is a research-driven company specialising in developing and ...

Senores Pharmaceuticals IPO Allotment Today: At the upper price band, the company is valued at a P/E of 55x with a market cap of Rs 1800.6 crore (Image: Freepik) The allotment of Senores ...

Senores Pharmaceuticals IPO allotment status: Investors can check their allotment by visiting the websites of the Bombay Stock Exchange (BSE) or Link Intime India. Listen to Story Senores Pharma IPO ...

Senores Pharmaceuticals is scheduled to finalise the basis of allotment of its shares on Thursday, December 26. Bidders will get the messages, alerts or emails for debit of their funds or ...

Senores Pharmaceuticals IPO share allotment will be finalized soon, with investors able to check their status via BSE or the registrar's website. The IPO saw a robust subscription of over 93.41 times, ...